Correlation Between Corvus Pharmaceuticals and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Keros Therapeutics, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Keros Therapeutics.
Diversification Opportunities for Corvus Pharmaceuticals and Keros Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Corvus and Keros is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Keros Therapeutics
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 1.72 times more return on investment than Keros Therapeutics. However, Corvus Pharmaceuticals is 1.72 times more volatile than Keros Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Keros Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 224.00 in Corvus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 671.00 from holding Corvus Pharmaceuticals or generate 299.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. Keros Therapeutics
Performance |
| Timeline |
| Corvus Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
| Keros Therapeutics |
Corvus Pharmaceuticals and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and Keros Therapeutics
The main advantage of trading using opposite Corvus Pharmaceuticals and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |